Cite
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
MLA
Paul G, O’Reilly, et al. “QUADrATiC: Scalable Gene Expression Connectivity Mapping for Repurposing FDA-Approved Therapeutics.” BMC Bioinformatics, vol. 17, no. 1, Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........32e59801c32727f0f7f0936c16fd1f1b&authtype=sso&custid=ns315887.
APA
Paul G, O., Qing, W., Peter, B., Philip D, D., Darragh G, M., Suzanne, M., Peter W, H., Ken I, M., & Shu-Dong, Z. (2016). QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics. BMC Bioinformatics, 17(1).
Chicago
Paul G, O’Reilly, Wen Qing, Bankhead Peter, Dunne Philip D, McArt Darragh G, McPherson Suzanne, Hamilton Peter W, Mills Ken I, and Zhang Shu-Dong. 2016. “QUADrATiC: Scalable Gene Expression Connectivity Mapping for Repurposing FDA-Approved Therapeutics.” BMC Bioinformatics 17 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........32e59801c32727f0f7f0936c16fd1f1b&authtype=sso&custid=ns315887.